List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 54 studies with search of: "Flavopiridol"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)
Condition: Leukemia, Lymphocytic, Chronic
Intervention: Drug: alvocidib (HMR1275)
2 Active, not recruiting Flavopiridol in Treating Patients With Metastatic Malignant Melanoma
Condition: Melanoma (Skin)
Intervention: Drug: alvocidib
3 Active, not recruiting Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma
Condition: Lymphoma
Intervention: Drug: alvocidib
4 Active, not recruiting Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: alvocidib
5 Completed Flavopiridol Plus Radiation Therapy Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: alvocidib;   Drug: gemcitabine hydrochloride;   Radiation: radiation therapy
6 Completed Flavopiridol, Oxaliplatin, Fluorouracil, and Leucovorin in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: alvocidib;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin
7 Recruiting Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Conditions: Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: alvocidib;   Drug: bortezomib
8 Recruiting Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: alvocidib;   Drug: cytarabine;   Drug: mitoxantrone hydrochloride
9 Completed Flavopiridol in Treating Patients With Recurrent Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: alvocidib
10 Completed Flavopiridol in Treating Patients With Refractory Cancer
Conditions: Lymphoma;   Prostate Cancer;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: alvocidib
11 Recruiting Flavopiridol in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: alvocidib
12 Completed Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Drug: alvocidib
13 Completed Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: alvocidib;   Drug: docetaxel
14 Active, not recruiting Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer;   Melanoma (Skin);   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: alvocidib;   Drug: carboplatin;   Drug: cisplatin
15 Completed Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia
Condition: Leukemia
Intervention: Drug: alvocidib
16 Completed Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: alvocidib
17 Completed Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: alvocidib
18 Completed Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer
Condition: Leukemia
Interventions: Drug: alvocidib;   Drug: imatinib mesylate
19 Completed Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: alvocidib;   Drug: gemcitabine hydrochloride;   Drug: irinotecan hydrochloride
20 Active, not recruiting Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: alvocidib;   Drug: irinotecan hydrochloride

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services